Congenital hypothyroidism in association with Caroli's disease and autosomal recessive polycystic kidney disease: Patient report

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 3, 2005, Pages 315-318

  Jeha, George S ^a   Tatevian, Nina ^a   Heptulla, Rubina A ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Autosomal recessive; Contraceptives; Cretinism; Fibrocystin polyductin; Oral; PKHD1; Polycystic kidney; Serotonin uptake inhibitors

Indexed keywords

ALBUMIN; BILIRUBIN; CALCIUM CHANNEL BLOCKING AGENT; CONTRACEPTIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBROCYSTIN; LEVOTHYROXINE; LIVER ENZYME; NITROGEN; PENTETATE TECHNETIUM TC 99M; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THYROTROPIN; THYROXINE; UREA;

ABDOMINAL DISTENSION; ALBUMIN BLOOD LEVEL; ANURIA; ARTICLE; ARTIFICIAL VENTILATION; AUTOSOMAL RECESSIVE DISORDER; BILIRUBIN BLOOD LEVEL; CAROLI DISEASE; CASE REPORT; CESAREAN SECTION; CHILDHOOD DISEASE; CLINICAL FEATURE; CONGENITAL HYPOTHYROIDISM; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY HYPERTROPHY; KIDNEY POLYCYSTIC DISEASE; KIDNEY SCINTISCANNING; LIVER FUNCTION TEST; LUNG HYPOPLASIA; NEPHRECTOMY; NEWBORN; OLIGOHYDRAMNIOS; PERITONEAL DIALYSIS; PROTEIN URINE LEVEL; RESPIRATORY DISTRESS; RISK FACTOR; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

EID: 15844418328     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.3.315     Document Type: Article

References (7)

1. Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 2003; 111: 1072-1080.
2. Satomura K, Michigami T, Yamamoto K, Hosokawa S. A case report of glomerulocystic kidney disease with hypothyroidism in a newborn infant [in Japanese]. Nippon Jinzo Gakkai Shi 1998; 40: 602-606.
3. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002; 30: 259-269.
4. Shuey DL, Sadler TW, Lauder JM. Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology 1992; 46: 367-378.
5. Oca MJ, Donn SM. Association of maternal sertraline (Zoloft) therapy and transient neonatal nystagmus. J Perinatol 1999; 19: 460-461.
6. Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, Ormond K, Matsui D, Stein-Schechman AK, Cook L, Brochu J, Rieder M, Koren G. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998; 279: 609-610.
7. Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol 1990; 76: 552-557.